WO2017031502A1 - Method for increasing muscle growth using krill extract - Google Patents

Method for increasing muscle growth using krill extract

Info

Publication number
WO2017031502A1
WO2017031502A1 PCT/US2016/048079 US2016048079W WO2017031502A1 WO 2017031502 A1 WO2017031502 A1 WO 2017031502A1 US 2016048079 W US2016048079 W US 2016048079W WO 2017031502 A1 WO2017031502 A1 WO 2017031502A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
mammal
composition
administering
method according
acid
Prior art date
Application number
PCT/US2016/048079
Other languages
English (en)
French (fr)
Inventor
David McCray PEELE
Ralf Jager
Martin Purpura
Original Assignee
Avoca, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/612Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
PCT/US2016/048079 2015-08-20 2016-08-22 Method for increasing muscle growth using krill extract WO2017031502A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201562207656 true 2015-08-20 2015-08-20
US62/207,656 2015-08-20

Publications (1)

Publication Number Publication Date
WO2017031502A1 true true WO2017031502A1 (en) 2017-02-23

Family

ID=58051070

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/048079 WO2017031502A1 (en) 2015-08-20 2016-08-22 Method for increasing muscle growth using krill extract

Country Status (1)

Country Link
WO (1) WO2017031502A1 (e)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078625A1 (en) * 2004-10-08 2006-04-13 Susie Rockway Compositions including krill extracts and conjugated linoleic acid and methods of using same
US20130108706A1 (en) * 2010-06-04 2013-05-02 Katja Svennevig Dietary formulations
US20140005421A1 (en) * 2007-03-28 2014-01-02 Aker Biomarine As Bioeffective krill oil compositions
US20140141074A1 (en) * 2009-10-29 2014-05-22 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
WO2014184655A1 (en) * 2013-02-07 2014-11-20 Olympic Seafood As Methods for using crustacean phospholipid-peptide-protein complexes
US20140357576A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078625A1 (en) * 2004-10-08 2006-04-13 Susie Rockway Compositions including krill extracts and conjugated linoleic acid and methods of using same
US20140005421A1 (en) * 2007-03-28 2014-01-02 Aker Biomarine As Bioeffective krill oil compositions
US20140141074A1 (en) * 2009-10-29 2014-05-22 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
US20130108706A1 (en) * 2010-06-04 2013-05-02 Katja Svennevig Dietary formulations
WO2014184655A1 (en) * 2013-02-07 2014-11-20 Olympic Seafood As Methods for using crustacean phospholipid-peptide-protein complexes
US20140357576A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis

Similar Documents

Publication Publication Date Title
Artioli et al. Role of beta-alanine supplementation on muscle carnosine and exercise performance
McKnight et al. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health
Fujita et al. Nutrient signalling in the regulation of human muscle protein synthesis
Ai et al. Effects of dietary vitamin C on survival, growth, and immunity of large yellow croaker, Pseudosciaena crocea
Levine Intermittent hypoxic training: fact and fancy
Mischoulon et al. Docosahexanoic acid and ω-3 fatty acids in depression
Joyner et al. Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs
Fujita et al. Essential amino acid and carbohydrate ingestion before resistance exercise does not enhance postexercise muscle protein synthesis
Drummond et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging
Furuita et al. Effect of different levels of eicosapentaenoic acid and docosahexaenoic acid in Artemia nauplii on growth, survival and salinity tolerance of larvae of the Japanese flounder, Paralichthys olivaceus
Smits et al. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia
Kraemer et al. Effects of amino acids supplement on physiological adaptations to resistance training
Landi et al. Exercise as a remedy for sarcopenia
Carrié et al. Diets containing long-chain n-3 polyunsaturated fatty acids affect behaviour differently during development than ageing in mice
Tsai et al. Study on the effect of megavitamin E supplementation in man
US20130059768A1 (en) Lipid compositions with high dha content
Eriksen et al. Cognitive activation theory of stress (CATS): from fish brains to the Olympics
Fitschen et al. Efficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations
Suminski et al. Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentration in young men
Martinez Docosahexaenoic acid therapy in docosahexaenoic acid‐deficient patients with disorders of peroxisomal biogenesis
Wilson et al. International Society of Sports Nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB)
WO2006127620A2 (en) Compositions containing pufa and methods of use thereof
Christaki et al. Effect of a mixture of herbal extracts on broiler chickens infected with Eimeria tenella
Deldicque et al. Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways
Robinson et al. Long-term synthesis rates of skeletal muscle DNA and protein are higher during aerobic training in older humans than in sedentary young subjects but are not altered by protein supplementation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16837961

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE